Features of patients and fracture risk in hypoparathyroidism; a single center study.

Bone Mineral Density Fractures Hypocalcemia Hypoparathyroidism Osteoporosis

Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
23 Aug 2023
Historique:
received: 09 04 2023
accepted: 16 08 2023
medline: 23 8 2023
pubmed: 23 8 2023
entrez: 23 8 2023
Statut: aheadofprint

Résumé

Patients with hypoparathyroidism (hypoPT) have low bone turnover and high bone mineral density (BMD). However, data on fracture risk are conflicting. The objectives of this study were: 1. To describe clinical/biochemical characteristics of hypoPT patients followed at a single medical center. 2. To identify postsurgical hypoPT patients and investigate their fracture rate compared with gender/age-matched post-surgical normocalcemic patients. Retrospective analysis of patient's medical records treated at the tertiary medical center in 2010-2021 identified by computerized medical database search. The cohort included 133 patients (91% women, mean age 64 ± 13 years) of whom 105 (79%) had post-thyroidectomy hypoparathyroidism and the remainder had an autoimmune/idiopathic/other etiology. Mean follow-up time was 21 ± 12 and 27 ± 12 years, respectively. The control group included 142 post-thyroidectomy patients without hypoparathyroidism. Patients in the postsurgical hypoparathyroidism group were older and had higher calcium and PTH levels at diagnosis than the non-surgical hypoPT patients. Comparing the postsurgical hypoPT and postsurgical normocalcemic control patients revealed a significantly higher BMD in the hypoPT group. Yet, fracture rates were 31% in the postsurgical hypoparathyroidism group and 21% in the control group (P = 0.1) over a similar median follow-up period (17 and 18.4 years, respectively). In both groups the most common fracture site was the spine (50% and 70%, respectively; p = 0.33), mainly nonclinical morphometric fractures. Higher phosphorus blood level was associated with increased fracture risk. The relatively high BMD in patients with postsurgical hypoparathyroidism is not associated with lower fracture risk. Silent morphometric fractures are quite common in this group of patients.

Identifiants

pubmed: 37610611
doi: 10.1007/s40618-023-02177-2
pii: 10.1007/s40618-023-02177-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Références

Gafni RI, Collins MT (2019) Hypoparathyroidism. N Engl J Med 18:1738–1747. https://doi.org/10.1056/NEJMcp1800213
doi: 10.1056/NEJMcp1800213
Bilezikian JP (2020) Hypoparathyroidism. J Clin Endocrinol Metab 6:1722–1736. https://doi.org/10.1210/clinem/dgaa113
doi: 10.1210/clinem/dgaa113
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism-risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 11:2504–2510. https://doi.org/10.1002/jbmr.2273
doi: 10.1002/jbmr.2273
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 11:2277–2285. https://doi.org/10.1002/jbmr.1979
doi: 10.1002/jbmr.1979
Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL, Rejnmark L, Shoback DM, Potts JT, Guyatt GH, Mannstadt M (2022) Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res 37(12):2568–2585. https://doi.org/10.1002/jbmr.4691
doi: 10.1002/jbmr.4691 pubmed: 36054621
Saponaro F, Alfi G, Cetani F et al (2022) Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 45:1909–1918. https://doi.org/10.1007/s40618-022-01822-6
doi: 10.1007/s40618-022-01822-6 pubmed: 35751804 pmcid: 9463210
Hanley DA, Watson PH, Hodsman AB, Dempster DW (2008) Pharmacological mechanisms of therapeutics: parathyroid hormone. In: Bilezikian JP, Raisz LG, Martin TJ (eds) Principles of bone biology, 3rd edn. Academic Press, Amsterdam, pp 1661–1695
Tay YD, Tabacco G, Bilezikian JP (2021) Bone quality in hypoparathyroidism. Minerva Endocrinol 46(3):325–334. https://doi.org/10.23736/S2724-6507.21.03527-2
doi: 10.23736/S2724-6507.21.03527-2
Abugassa S, Nordenström J, Eriksson S, Sjödén G (1993) Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 6:1617–1621. https://doi.org/10.1210/jcem.76.6.8501170
doi: 10.1210/jcem.76.6.8501170
Fujiyama K, Kiriyama T, Ito M, Nakata K, Yamashita S, Yokoyama N, Nagataki S (1995) Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab 7:2135–2138. https://doi.org/10.1210/jcem.80.7.7608266
doi: 10.1210/jcem.80.7.7608266
Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, Silverberg SJ, Bilezikian JP (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 12:2018–2024. https://doi.org/10.1359/jbmr.080803
doi: 10.1359/jbmr.080803
Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP (2019) Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol (Oxf) 2:285–292. https://doi.org/10.1111/cen.13895
doi: 10.1111/cen.13895
Formenti AM, Tecilazich F, Giubbini R, Giustina A (2019) Risk of vertebral fractures in hypoparathyroidism. Rev Endocr Metab Disord 3:295–302. https://doi.org/10.1007/s11154-019-09507-x
doi: 10.1007/s11154-019-09507-x
Mendonça ML, Pereira FA, Nogueira-Barbosa MH, Monsignore LM, Teixeira SR, Watanabe PC, Maciel LM, de Paula FJ (2013) Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr Disord 13(13):1–8. https://doi.org/10.1186/1472-6823-13-1
doi: 10.1186/1472-6823-13-1 pubmed: 23286605 pmcid: 3546901
Cipriani C, Minisola S, Bilezikian JP, Diacinti D, Colangelo L, Piazzolla V, Angelozzi M, Nieddu L, Pepe J, Diacinti D (2021) Vertebral fracture assessment in postmenopausal women with postsurgical hypoparathyroidism. J Clin Endocrinol Metab 5:1303–1311. https://doi.org/10.1210/clinem/dgab076
doi: 10.1210/clinem/dgab076
Chawla H, Saha S, Kandasamy D, Sharma R, Sreenivas V, Goswami R (2017) Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up. J Clin Endocrinol Metab 1:251–258. https://doi.org/10.1210/jc.2016-3292
doi: 10.1210/jc.2016-3292
Kim SH, Rhee Y, Kim YM, Won YJ, Noh J, Moon H, Lee J, Kim SG (2020) Prevalence and complications of nonsurgical hypoparathyroidism in Korea: a nationwide cohort study. PLoS ONE 5:e0232842. https://doi.org/10.1371/journal.pone.0232842
doi: 10.1371/journal.pone.0232842
Genant HK, Wu CY, van Kujik C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 9:1137–1148. https://doi.org/10.1002/jbmr.5650080915
doi: 10.1002/jbmr.5650080915
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 9:1738–1744. https://doi.org/10.1002/jbmr.2501
doi: 10.1002/jbmr.2501
d’Alva CB, Barreto ARF, Nogueira-Barbosa MH, Arruda CCC, Albuquerque ÁM, Praciano DMC, Viana RP, Gadelha DD, Viana AB Jr, Moreira IM, de Moura Filho FJR, Junqueira AFTA, Montenegro RM (2022) Morphometric vertebral fracture risk in women with postsurgical hypoparathyroidism. Front Endocrinol (Lausanne). 13:9485. https://doi.org/10.3389/fendo.2022.948435 . (eCollection 2022. PMID: 36619538)
doi: 10.3389/fendo.2022.948435
Pal R, Bhadada SK, Mukherjee S, Banerjee M, Kumar A (2021) Fracture risk in hypoparathyroidism: a systematic review and meta-analysis. Osteoporos Int 11:2145–2153. https://doi.org/10.1007/s00198-021-05966-8
doi: 10.1007/s00198-021-05966-8
Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 12:4507–4514. https://doi.org/10.1210/jc.2012-1808 . (Epub 2012 Oct 5)
doi: 10.1210/jc.2012-1808
Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC (2003) Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 7:155–3159. https://doi.org/10.1210/jc.2002-021388
doi: 10.1210/jc.2002-021388
Johansson L, Sundh D, Magnusson P, Rukmangatharajan K, Mellström D, Nilsson A, Lorentzon M (2020) Grade 1 vertebral fractures identified by densitometric lateral spine imaging predict incident major osteoporotic fracture independently of clinical risk factors and bone mineral density in older women. JBMR 10:1942–1951. https://doi.org/10.1002/jbmr.4108
doi: 10.1002/jbmr.4108
Ott SM (2018) Cortical or trabecular bone: what’s the difference? Am J Nephrol 6:373–375. https://doi.org/10.1159/000489672
doi: 10.1159/000489672
Campos-Obando N, Koek WNH, Hooker ER, van der Eerden BC, Pols HA, Hofman A, van Leeuwen JP, Uitterlinden AG, Nielson CM, Zillikens MC (2017) Serum phosphate is associated with fracture risk: the Rotterdam study and MrOS. J Bone Miner Res 32:1182–1193. https://doi.org/10.1002/jbmr.3094
doi: 10.1002/jbmr.3094 pubmed: 28177140
Zhang R, Lu Y, Ye L, Yuan B, Yu S, Qin C, Xie Y, Gao T, Drezner MK, BonewaldL F, Feng JQ (2011) Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J Bone Miner Res 26:1047–1056. https://doi.org/10.1002/jbmr.294
doi: 10.1002/jbmr.294 pubmed: 21542006
Koyama Y, Rittling SR, Tsuji K, Hino K, Salincarnboriboon R, Yano T, Taketani Y, Nifuji A, Denhardt D, Noda M (2016) Osteopontin deficiency suppresses high phosphate load- induced bone loss via specific modulation of osteoclasts. Endocrinology 147(2016):3040–3047. https://doi.org/10.1210/en.2005-0671
doi: 10.1210/en.2005-0671

Auteurs

I Slutzky-Shraga (I)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel. shraga_ilana@hotmail.com.
Clalit Healthcare Services, Yaffo District, Tel Aviv, Israel. shraga_ilana@hotmail.com.
Department of Endocrinology, Diabetes & Metabolism, Rabin Medical Center - Beilinson Hospital, 39 Jabotinski St., 4941492, Petach Tikva, Israel. shraga_ilana@hotmail.com.

D Hirsch (D)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

A Gorshtein (A)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

H Masri-Iraqi (H)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

T Shochat (T)

Statistical Consulting Unit, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

E Robenshtok (E)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

I Shimon (I)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

G Tsvetov (G)

Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Classifications MeSH